Literature DB >> 23089703

Genetic-based reference values for angiotensin-converting enzyme (ACE) according to I/D polymorphism in a Spanish population sample.

Silvia Camós1, M Jesús Cruz, Ferran Morell, Esther Solé.   

Abstract

BACKGROUND: Serum angiotensin-converting enzyme (ACE) activity has been related to sarcoidosis and other granulomatous diseases. It has been demonstrated that serum ACE activity is influenced by ACE gene I/D polymorphism. The aim of this study was to establish ACE activity reference values according to genotype in a Spanish population to improve diagnostic sensitivity and treatment monitoring in sarcoidosis patients.
METHODS: A sample population of 150 blood donors was included in the study. Serum ACE activity and genotype were determined and the reference intervals, defined as the 95% central range of the population (2.5th-97.5th percentiles) were obtained for all three genotypes (DD, DI, II) and for the entire sample.
RESULTS: Genotype frequencies were 37% DD (n=54), 43% DI (n=63), and 20% II (n=30). Individuals with DD genotype showed the highest ACE activity (mean 39.0 U/L, SD 13.6), ID genotype showed intermediate levels (mean 29.5 U/L, SD 10.2) and II genotype lowest levels (mean 19.1 U/L, SD 4.9). ACE activity differed significantly between these groups: F (2144)=33.15, p<0.05. The corresponding reference intervals for ACE activity were 13.3-63.9 U/L in the overall sample, 12.3-65.6 U/L in genotype DD, 9.5-49.5 U/L in DI and 9.6-28.7 in II.
CONCLUSIONS: The preliminary reference values for ACE activity in healthy Spanish individuals according to I/D polymorphism are presented. Significant differences in these values were found between the genotype groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089703     DOI: 10.1515/cclm-2012-0042

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

1.  Genetic susceptibility to nosocomial pneumonia, acute respiratory distress syndrome and poor outcome in patients at risk of critical illness.

Authors:  Lyubov E Salnikova; Tamara V Smelaya; Irina N Vesnina; Arkadiy M Golubev; Viktor V Moroz
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

2.  Analysis of the Pattern, Alliance and Risk of rs1799752 (ACE I/D Polymorphism) with Essential Hypertension.

Authors:  Digishaben D Patel; Deepak N Parchwani; Nirupama Dikshit; Tanishk Parchwani
Journal:  Indian J Clin Biochem       Date:  2020-10-31

3.  Robust arm and leg muscle adaptation to training despite ACE inhibition: a randomized placebo-controlled trial.

Authors:  Tórur Sjúrðarson; Jacob Bejder; Andreas Breenfeldt Andersen; Thomas C Bonne; Kasper Kyhl; Martin Thomassen; Júlia Prats; Noomi Oddmarsdóttir Gregersen; May-Britt Skoradal; Pál Weihe; Nikolai B Nordsborg; Magni Mohr
Journal:  Eur J Appl Physiol       Date:  2022-10-22       Impact factor: 3.346

4.  The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings.

Authors:  Robert Kieszko; Paweł Krawczyk; Tomasz Powrózek; Aneta Szudy-Szczyrek; Michał Szczyrek; Iwona Homa; Jadwiga Daniluk; Janusz Milanowski
Journal:  Arch Med Sci       Date:  2015-04-28       Impact factor: 3.318

5.  Associations of ACE gene insertion/deletion polymorphism, ACE activity, and ACE mRNA expression with hypertension in a Chinese population.

Authors:  Qingfang He; Chunhong Fan; Min Yu; Gina Wallar; Zuo-Feng Zhang; Lixin Wang; Xinwei Zhang; Ruying Hu
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.